Aligos Therapeutics Statistics

Total Valuation

ALGS has a market cap or net worth of $39.01 million. The enterprise value is -$9.56 million.

Market Cap	39.01M
Enterprise Value	-9.56M

Important Dates

The last earnings date was Monday, March 10, 2025, before market open.

Earnings Date	Mar 10, 2025
Ex-Dividend Date	n/a

Share Statistics

ALGS has 3.71 million shares outstanding. The number of shares has increased by 144.38% in one year.

Current Share Class	3.59M
Shares Outstanding	3.71M
Shares Change (YoY)	+144.38%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	4.73%
Owned by Institutions (%)	25.38%
Float	1.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	16.69
Forward PS	28.68
PB Ratio	-1.35
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.86

Current Ratio	2.86
Quick Ratio	2.62
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -415.84% and return on invested capital (ROIC) is -134.89%.

Return on Equity (ROE)	-415.84%
Return on Assets (ROA)	-50.29%
Return on Invested Capital (ROIC)	-134.89%
Return on Capital Employed (ROCE)	-184.37%
Revenue Per Employee	$59,773
Profits Per Employee	-$1.99M
Employee Count	66
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

In the past 12 months, ALGS has paid $331,000 in taxes.

Income Tax	331,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -49.96% in the last 52 weeks. The beta is 2.52, so ALGS's price volatility has been higher than the market average.

Beta (5Y)	2.52
52-Week Price Change	-49.96%
50-Day Moving Average	26.63
200-Day Moving Average	17.68
Relative Strength Index (RSI)	22.24
Average Volume (20 Days)	239,138

Short Selling Information

The latest short interest is 712,993, so 19.21% of the outstanding shares have been sold short.

Short Interest	712,993
Short Previous Month	576,358
Short % of Shares Out	19.21%
Short % of Float	36.41%
Short Ratio (days to cover)	2.65

Income Statement

In the last 12 months, ALGS had revenue of $3.95 million and -$131.21 million in losses. Loss per share was -$20.94.

Revenue	3.95M
Gross Profit	-66.32M
Operating Income	-89.15M
Pretax Income	-75.52M
Net Income	-131.21M
EBITDA	-88.13M
EBIT	-89.15M
Loss Per Share	-$20.94

Full Income Statement

Balance Sheet

The company has $56.94 million in cash and $8.38 million in debt, giving a net cash position of $48.56 million or $13.08 per share.

Cash & Cash Equivalents	56.94M
Total Debt	8.38M
Net Cash	48.56M
Net Cash Per Share	$13.08
Equity (Book Value)	-28.97M
Book Value Per Share	-4.61
Working Capital	40.40M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$80.74 million and capital expenditures -$130,000, giving a free cash flow of -$80.87 million.

Operating Cash Flow	-80.74M
Capital Expenditures	-130,000
Free Cash Flow	-80.87M
FCF Per Share	-$21.79

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-2,259.92%
Pretax Margin	-3,317.62%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ALGS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-144.38%
Shareholder Yield	-144.38%
Earnings Yield	-336.36%
FCF Yield	-207.32%

Analyst Forecast

The average price target for ALGS is $70.00, which is 566.03% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$70.00
Price Target Difference	566.03%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	165.77%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on August 19, 2024. It was a reverse split with a ratio of 0.04:1.

Last Split Date	Aug 19, 2024
Split Type	Reverse
Split Ratio	0.04:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1